Deletion of the LDHB gene inhibited tumor initiation and progression through mitochondrial DNA damage in a genetically engineered NSCLC mouse model with combined p53 knockout and KRAS (G12D) overexpression (Deng et al., 2022; Stine et al., 2022). This evidence concerns the gene KRAS and non-small cell lung carcinoma.